Status:

COMPLETED

Protocol PERCAF 2018

Lead Sponsor:

Institut de Recherche Biomedicale des Armees

Conditions:

Sleep

Caffeine

Eligibility:

All Genders

18-50 years

Phase:

NA

Brief Summary

In this multicentric controlled study, we aims to evaluate effect of caffeine on mental performances during a sleep deprivation protocol. Genetic polymorphisms are considered as a covariable.

Detailed Description

Coffee is the most consumed arousing substance in the world. Caffeine is used as a natural countermeasure to maintain the performance of sleep deprived subjects. However, the effectiveness of caffeine...

Eligibility Criteria

Inclusion

  • healthy subject

Exclusion

  • Treatment
  • History of cardiovascular, psychiatric, pneumologic, haematologic, cancerology disease
  • Nonvoluntary
  • Pregnancy

Key Trial Info

Start Date :

September 2 2018

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

June 26 2019

Estimated Enrollment :

52 Patients enrolled

Trial Details

Trial ID

NCT03859882

Start Date

September 2 2018

End Date

June 26 2019

Last Update

August 27 2021

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

Institut de recherche biomedical des armées

Brétigny-sur-Orge, France

2

Hotel Dieu

Paris, France, 75004